PEA may provide joint relief for projected ‘silver’ population

With an aging population increasingly suffering from Osteoarthritis (OA), questions about the efficacy of chondroitin and glucosamine products, the market for new natural alternatives to analgesics is primed for growth.

1 Min Read
PEA may provide joint relief.jpg

Osteoarthritis (OA) is the most common joint disorder, according to the CDC, affecting more than 32 million people in the U.S. alone. The European Medical Journal reported that globally, 18% of women and 9.6% of men above age 60 suffer from OA.

With the current growth rate, the U.N. estimated the aging population will double to approximately 1.5 billion by 2050, increasing the number of people experiencing OA and its public health and economic burden. The 2017 Innova Consumer Market Insights Survey reported joint health as an extreme concern for 17 to 20% of consumers in the U.K. and U.S. Innova research also revealed 57% of Chinese consumers consider joint health a top health concern.

The CDC also states that analgesics such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen are used chronically to alleviate OA pain symptoms without resulting in its cure. This may increase the risk of existing adverse events. Although chondroitin and glucosamine products have long garnered attention in the joint health market, study results on their efficacy have been conflicting.

The need for early, safe and fast intervention in joint health and the interlink of central and peripheral effects in OA are dire.

Gencor studied PEA in an eight-week, single-site comparative human clinical trial which demonstrated the ingredient’s all-around effectiveness and safety. PEA has also shown to improve quality of life by significantly reducing anxiety.

To read this article in its entirety, check out the Joint Health digital magazine.

Silma Subah and Nathasha Omal Bogoda are research associates at Gencor Pacific Ltd.

About the Author(s)

Silma Subah

Research associate, Gencor

Silma Subah is a research associate at Gencor Pacific Limited. She received a Bachelor's of Applied Science Degree for Biochemistry from the Univeristy of Hong Kong. 

Nathasha Bogoda

Research associate, Gencor

Nathasha Bogoda is a research associate at Gencor Pacific Limited. She received a Bachelor's of Applied Science Degree for Biomedical Sciences from the University of Hong Kong. 

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like